These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17913549)

  • 1. Cardiovascular disease in patients with spondyloarthropathies.
    Vinsonneau U; Brondex A; Mansourati J; Saraux A; Cornily JC; Arlès F; Godon P; Quiniou G
    Joint Bone Spine; 2008 Jan; 75(1):18-21. PubMed ID: 17913549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spondyloarthropathies: an independent cardiovascular risk factor?
    Mathieu S; Motreff P; Soubrier M
    Joint Bone Spine; 2010 Dec; 77(6):542-5. PubMed ID: 20646947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predisposing factors in the spondyloarthropathies: new insights into the role of HLA-B27.
    Colbert RA; Prahalad S
    Curr Rheumatol Rep; 2001 Oct; 3(5):404-11. PubMed ID: 11564372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The genetics of spondyloarthropathies.
    Breban M; Miceli-Richard C; Zinovieva E; Monnet D; Said-Nahal R
    Joint Bone Spine; 2006 Jul; 73(4):355-62. PubMed ID: 16650794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on spondyloarthropathies.
    Khan MA
    Ann Intern Med; 2002 Jun; 136(12):896-907. PubMed ID: 12069564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological management of undifferentiated spondyloarthropathies.
    Palazzi C; Padula A; Montaruli M; Pennese E; Olivieri I
    Expert Opin Investig Drugs; 2006 Jan; 15(1):39-46. PubMed ID: 16370932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The intimate relationship between gut and joint in spondyloarthropathies.
    Jacques P; Mielants H; Coppieters K; De Vos M; Elewaut D
    Curr Opin Rheumatol; 2007 Jul; 19(4):353-7. PubMed ID: 17551365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ankylosing spondylitis and related spondyloarthropathies: the dramatic advances in the past decade.
    Khan MA
    Rheumatology (Oxford); 2011 Apr; 50(4):637-9. PubMed ID: 21421688
    [No Abstract]   [Full Text] [Related]  

  • 9. What is the role of HLA-B27 in spondyloarthropathies?
    Chatzikyriakidou A; Voulgari PV; Drosos AA
    Autoimmun Rev; 2011 Jun; 10(8):464-8. PubMed ID: 21296192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spondyloarthropathies: using presentation to make the diagnosis.
    Kiratiseavee S; Brent LH
    Cleve Clin J Med; 2004 Mar; 71(3):184-5, 189, 192-4 passim. PubMed ID: 15055243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The HLA-B*2709 subtype confers susceptibility to spondylarthropathy.
    Olivieri I; Ciancio G; Padula A; Gaudiano C; Masciandaro S; Moro L; Durante E; Pozzi S; Ferrara GB
    Arthritis Rheum; 2002 Feb; 46(2):553-4. PubMed ID: 11840459
    [No Abstract]   [Full Text] [Related]  

  • 12. HLA-B*2709 and spondylarthropathies: comment on the concise communication by Olivieri et al.
    Mathieu A; Sorrentino R
    Arthritis Rheum; 2003 Mar; 48(3):866-7; author reply 867-8. PubMed ID: 12632458
    [No Abstract]   [Full Text] [Related]  

  • 13. Geoepidemiology: the environment and spondyloarthropathies.
    Ehrenfeld M
    Autoimmun Rev; 2010 Mar; 9(5):A325-9. PubMed ID: 20026258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review for Disease of the Year: Epidemiology of HLA-B27 Associated Ocular Disorders.
    Kopplin LJ; Mount G; Suhler EB
    Ocul Immunol Inflamm; 2016 Aug; 24(4):470-5. PubMed ID: 27232197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CARD15 gene polymorphisms in patients with spondyloarthropathies identify a specific phenotype previously related to Crohn's disease.
    Laukens D; Peeters H; Marichal D; Vander Cruyssen B; Mielants H; Elewaut D; Demetter P; Cuvelier C; Van Den Berghe M; Rottiers P; Veys EM; Remaut E; Steidler L; De Keyser F; De Vos M
    Ann Rheum Dis; 2005 Jun; 64(6):930-5. PubMed ID: 15539413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of patients with spondyloarthropathies for treatment with tumour necrosis factor alpha blockade.
    Paul S; Keat A
    Rheumatology (Oxford); 2005 Jan; 44(1):17-23. PubMed ID: 15328421
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiovascular comorbidities in spondyloarthritis.
    Bodur H
    Clin Rheumatol; 2023 Oct; 42(10):2611-2620. PubMed ID: 36512164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk factors of cardiovascular complications in inflammatory seronegative spondyloarthropathies].
    Ozdowska P; Dąbrowski R; Głuszko P; Szwed H
    Kardiol Pol; 2013; 71(4):417-20. PubMed ID: 23788351
    [No Abstract]   [Full Text] [Related]  

  • 19. [Uveitis in spondyloarthritis].
    Rudwaleit M; Walscheid K; Heiligenhaus A
    Z Rheumatol; 2017 Oct; 76(8):682-692. PubMed ID: 28812149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A plea for reason in using magnetic resonance imaging for the diagnostic and therapeutic management of spondyloarthropathies.
    Goupille P; Pham T; Claudepierre P; Wendling D
    Joint Bone Spine; 2009 Mar; 76(2):123-5. PubMed ID: 19211286
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.